About a year and a half ago, I decided that simply choosing annual picks for the following year sometime in mid December was leaving potential opportunities on the table the rest of the year. That’s when I decided to launch mid year #SealOfApproval picks for those special opportunities that arise.
D-Box Technologies ($DBO.TO) was my first in February of last year and as of today that has delivered a return of 762%. Fast forward to February of this year and Biorem became my first mid year pick of 2026 at $2.42. It is currently up 25% from that selection, peaking at 48% or $3.57 in May after their first quarter was released which became a “sell the news” event. A move which I was puzzled by particularly since those financials received an upgrade to four stars and their second consecutive upgrade as well.
Prior to their financials coming out this morning, they traded at an 11.3 P/E with an EV/EBITDA ratio of just 5.9.
The headlines appear very impressive with a 66% revenue increase and increasing their profitability by over 260%. So, could we be looking at a company about to set new all time highs ($3.80), or are there some fly’s in the ointment we must consider?
Let’s find out.